Literature DB >> 30845070

T-cell and B-cell perturbations identify distinct differences in HIV-2 compared with HIV-1-induced immunodeficiency.

Bo L Hønge1,2, Mikkel S Petersen2, Sanne Jespersen1,3, Candida Medina4, David D S Té4, Bertram Kjerulff2, Thomas Engell-Sørensen1,3, Tina Madsen1,3, Alex L Laursen3, Christian Wejse1,3,5, Henrik Krarup6, Bjarne K Møller2, Christian Erikstrup2.   

Abstract

BACKGROUND: For unknown reasons, HIV-2 is less pathogenic than HIV-1, and HIV-2-induced immunodeficiency may be different from that caused by HIV-1. Previous immunological studies have hinted at possible shifts in both T-cell and B-cell subsets, which we aimed to characterize further.
METHODS: From an HIV clinic in Guinea-Bissau, 63 HIV-2, 83 HIV-1, and 26 HIV-negative participants were included. All HIV-infected participants were ART-naive. The following cell subsets were analysed by flow cytometry; T cells (maturation and activation), regulatory T cells, and B cells (maturation and activation).
RESULTS: After standardizing for sex, age, and CD4 T-cell count HIV-2 had 0.938 log10 copies/ml lower HIV RNA levels than the HIV-1-infected patients. Whereas T-cell maturation and regulatory T-cell profiles were similar between patients, HIV-2-infected patients had higher proportions of CD8CD28 and lower proportions of CD8PD-1+ T cells than HIV-1-infected patients. This finding was independent of HIV RNA levels. HIV-2 was also associated with a more preserved proportion of naive B cells.
CONCLUSION: HIV-2 is characterized by lower viral load, and lower T-cell activation, which may account for the slower disease progression.

Entities:  

Mesh:

Year:  2019        PMID: 30845070     DOI: 10.1097/QAD.0000000000002184

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

Review 1.  HIV-2 as a model to identify a functional HIV cure.

Authors:  Joakim Esbjörnsson; Marianne Jansson; Sanne Jespersen; Fredrik Månsson; Bo L Hønge; Jacob Lindman; Candida Medina; Zacarias J da Silva; Hans Norrgren; Patrik Medstrand; Sarah L Rowland-Jones; Christian Wejse
Journal:  AIDS Res Ther       Date:  2019-09-05       Impact factor: 2.250

2.  Computational Modulation of the V3 Region of Glycoprotein gp125 of HIV-2.

Authors:  Patrícia A Serra; Nuno Taveira; Rita C Guedes
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

3.  Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4+ T Cells in the Pathogenesis of HIV-2 Infection and Disease Progression.

Authors:  Sivasankaran Munusamy Ponnan; K K Vidyavijayan; Kannan Thiruvengadam; Nancy Hilda J; Manikannan Mathayan; Kailapuri Gangatharan Murugavel; Luke Elizabeth Hanna
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

4.  Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals.

Authors:  Lydia Scharf; Christina B Pedersen; Emil Johansson; Jacob Lindman; Lars R Olsen; Marcus Buggert; Sten Wilhelmson; Fredrik Månsson; Joakim Esbjörnsson; Antonio Biague; Patrik Medstrand; Hans Norrgren; Annika C Karlsson; Marianne Jansson
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

5.  Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection.

Authors:  Emil Johansson; Priscilla F Kerkman; Lydia Scharf; Jacob Lindman; Zsófia I Szojka; Fredrik Månsson; Antonio Biague; Patrik Medstrand; Hans Norrgren; Marcus Buggert; Annika C Karlsson; Mattias N E Forsell; Joakim Esbjörnsson; Marianne Jansson
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.